Tempus AI (NASDAQ:TEM) Issues Earnings Results, Misses Expectations By $0.18 EPS

Tempus AI (NASDAQ:TEM) announced its quarterly earnings data on Monday. The company reported ($0.33) earnings per share for the quarter, missing the consensus estimate of ($0.15) by ($0.18), Zacks reports. Tempus AI updated its FY 2025 guidance to EPS.

Tempus AI Trading Up 2.2 %

Shares of TEM stock opened at $69.57 on Tuesday. Tempus AI has a 12-month low of $22.89 and a 12-month high of $91.45. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The firm has a fifty day moving average of $50.88 and a 200-day moving average of $52.03.

Insider Activity at Tempus AI

In other Tempus AI news, CEO Eric P. Lefkofsky sold 476,209 shares of the company’s stock in a transaction that occurred on Wednesday, January 22nd. The stock was sold at an average price of $49.84, for a total transaction of $23,734,256.56. Following the completion of the transaction, the chief executive officer now owns 6,502,643 shares of the company’s stock, valued at $324,091,727.12. This represents a 6.82 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, major shareholder Bradley A. Keywell sold 265,000 shares of Tempus AI stock in a transaction that occurred on Friday, January 17th. The shares were sold at an average price of $35.10, for a total transaction of $9,301,500.00. Following the completion of the sale, the insider now owns 15,218,365 shares in the company, valued at $534,164,611.50. This trade represents a 1.71 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 2,583,467 shares of company stock valued at $130,542,311.

Analyst Ratings Changes

TEM has been the subject of a number of recent research reports. Needham & Company LLC reissued a “buy” rating and set a $56.00 price target on shares of Tempus AI in a research note on Tuesday, January 14th. Loop Capital decreased their price objective on Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research note on Tuesday, January 14th. Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and increased their target price for the company from $45.00 to $65.00 in a research note on Monday, November 11th. William Blair lowered Tempus AI from an “outperform” rating to a “market perform” rating in a research report on Wednesday, February 12th. Finally, Piper Sandler reiterated a “neutral” rating and issued a $70.00 price target (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $59.27.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.